Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 19-08-2026
NAV ₹18.09(R) +0.23% ₹19.02(D) +0.24%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 18.48% 19.98% -% -% -%
Direct 20.4% 21.94% -% -% -%
Nifty Pharma TRI 19.97% 20.53% 14.18% 19.98% 9.31%
SIP (XIRR) Regular 32.88% 15.78% -% -% -%
Direct 34.97% 17.64% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
- -
- -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 19-08-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - Growth Option - Regular Plan 18.09
0.0400
0.2300%
quant Healthcare Fund - IDCW Option - Regular Plan 18.09
0.0400
0.2300%
quant Healthcare Fund - Growth Option - Direct Plan 19.02
0.0400
0.2400%
quant Healthcare Fund - IDCW Option - Direct Plan 19.02
0.0400
0.2400%

Review Date: 19-08-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 4.86 1.28
2.10
-1.46 | 4.86 1 | 15 Very Good
3M Return % 11.85 6.18
8.60
2.76 | 12.49 4 | 15 Very Good
6M Return % 22.15 17.77
19.32
12.73 | 24.61 6 | 15 Good
1Y Return % 18.48 19.97
15.41
7.06 | 22.92 6 | 14 Good
3Y Return % 19.98 20.53
20.11
17.79 | 21.81 6 | 8 Average
1Y SIP Return % 32.88
26.04
-5.89 | 37.89 6 | 14 Good
3Y SIP Return % 15.78
14.49
4.97 | 18.11 4 | 8 Good
Return data last Updated On : Aug. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 5.01 1.28 2.21 -1.41 | 5.01 1 | 15 Very Good
3M Return % 12.31 6.18 8.97 2.96 | 12.97 4 | 15 Very Good
6M Return % 23.14 17.77 20.16 13.22 | 25.65 6 | 15 Good
1Y Return % 20.40 19.97 17.06 7.93 | 24.32 6 | 14 Good
3Y Return % 21.94 20.53 21.65 18.85 | 22.82 6 | 8 Average
1Y SIP Return % 34.97 27.80 -4.55 | 40.16 6 | 14 Good
3Y SIP Return % 17.64 15.97 6.48 | 19.83 4 | 8 Good
Return data last Updated On : Aug. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
19-08-2026 18.0878 19.0241
18-08-2026 18.0461 18.9794
17-08-2026 17.936 18.8628
14-08-2026 17.7762 18.6922
13-08-2026 17.9313 18.8544
12-08-2026 17.9174 18.839
11-08-2026 17.932 18.8535
10-08-2026 17.7737 18.6862
07-08-2026 17.7428 18.6513
06-08-2026 17.5173 18.4134
05-08-2026 17.6483 18.5502
04-08-2026 17.6293 18.5295
03-08-2026 17.5036 18.3965
31-07-2026 17.4426 18.3299
30-07-2026 17.0649 17.9321
29-07-2026 17.3292 18.2091
28-07-2026 16.8882 17.7449
27-07-2026 16.941 17.7997
24-07-2026 16.7656 17.613
23-07-2026 16.8447 17.6953
22-07-2026 17.144 18.0089
21-07-2026 17.3184 18.1913
20-07-2026 17.2487 18.1173

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.